:


American Academy of Child and Adolescent Psychiatry: Summary of the practice parameter for the use of stimulant medication in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2001; 40:1352-5.

American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder: Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/ hyperactivity disorder. Pediatrics 2000; 105: 1158- 70.

American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder: Clinical practice guideline: Treatment of the school-aged child with Attention-Deficit/Hyperactivity Disorder. Pediatrics 2001; 108: 1033- 44.

Barkley R. A, Murphy K.R., Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996; 98:1089-95.

Biederman J. Wilens T., Mick E. et al. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104: e20.

Jensen P. S.j Kettle L., Roper M. et al. Are stimulants over- prescribed? Treatment of ADHD in four U. S. communities. J Am Acad Child Adolesc Psychiatry 1999; 38: 797-804.

Liebson C. L., Katusic S. K., Barbaresi W. I. et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001; 285: 60-6.

MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56: 1073-86.

Pliszka S. R., Greenhill L. I., Crismon M. L et al. The Texas Children's Medication Algorithm Project: Report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. J Am Acad Child Adolesc Psychiatry 2000; 39: 908-19.

Pliszka S. R.t Greenhill L. I., Crismon M. L. et al. The Texas Children's Medication Algorithm Project: Report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: Tactics. J Am Acad Child Adolesc Psychiatry 2000; 39:920-7.

Wolraich M. L., Greenhill L. I., Pelham W. et al. Randomized controlled trial of OROS Methylphenidate once a day in children with Attention-Deficit/Hyperactivity order. Pediatrics 2001; 108: 883-92.

:

  • ()